Anticorps Recombinant de lapin anti-GBP3

GBP3 Recombinant Antibody for WB, FC (Intra), ELISA

Hôte / Isotype

Lapin / IgG

Réactivité testée

Humain

Applications

WB, FC (Intra), ELISA

Conjugaison

Non conjugué

CloneNo.

230178D8

N° de cat : 83534-1-PBS

Synonymes

GTP-binding protein 3, GTP binding protein 3, GBP-3, GBP 3, EC:3.6.5.-

---

Galerie de données de validation

• 

  WB analysis using 83534-1-RR (same clone as 83534-1-PBS)

  Various lysates were subjected to SDS PAGE followed by western blot with 83534-1-RR (GBP3 antibody) at dilution of 1:1000 incubated at room temperature for 1.5 hours. This data was developed using the same antibody clone with 83534-1-PBS in a different storage buffer formulation.

• 

  FC experiment of HT-29 using 83534-1-RR (same clone as 83534-1-PBS)

  1x10^6 HT-29 cells were intracellularly stained with 0.25 ug Gbp3 Recombinant Antibody (83534-1-RR, Clone:230178D8) and APC-Conjugated AffiniPure Goat Anti-Rabbit IgG(H+L)(red), or 0.25 ug Isotype Control (blue). Cells were fixed with 4% PFA and permeabilized with Flow Cytometry Perm Buffer (PF00011-C). This data was developed using the same antibody clone with 83534-1-PBS in a different storage buffer formulation.

• 

  Affinity and Kinetic Characterization of 83534-1-RR

  Biolayer interferometry (BLl) kinetic assays of 83534-1-RR against Human GBP3 were performed. The affinity constant is below 1 pM.

---

Informations sur le produit

83534-1-PBS cible GBP3 dans les applications de WB, FC (Intra), ELISA et montre une réactivité avec des échantillons Humain

• Réactivité: Humain
• Hôte / Isotype: Lapin / IgG
• Clonalité: Recombinant
• Type: Anticorps
• Immunogène: GBP3 Protéine recombinante Ag33889
• Nom complet: guanylate binding protein 3
• Numéro d’acquisition GenBank: BC140837
• Symbole du gène: GBP3
• Identification du gène (NCBI): 2635
• Conjugaison: Non conjugué
• Forme: Liquide
• Méthode de purification: Protein A purfication
• Tampon de stockage: PBS only
• Conditions de stockage: Store at -80°C. 20ul contiennent 0,1% de BSA.

{{ptg:RelatedPrimaryAntibodies}}